4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001586785-26-000006
Chief Executive Officer acquired 100,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
NEIL GARRY ARTHUR · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-21 | Grant or award : show line 1 in the form | +100,200 | 190,314 | D |
Loading xslF345X06/form4-05262026_040501.xml…